SoftOx Solutions AS ("SoftOx" or the "Company"), a clinical-stage biopharmaceutical company, with a separate disinfection branch inNorway , has received theSwedish Chemicals Agency's final product assessment draft for the SoftOx disinfection family. SoftOx has reviewed the report and notified the Agency that the company fully supports it. The next step is a final decision on the application for SoftOx's hand- and surface disinfectants. With an approval from theSwedish Chemicals Agency , SoftOx can apply for mutual recognition in sequence in any EU market, includingNorway . Furthermore, in parallel and in line with the company's strategy, SoftOx will initiate talks with several potential distributors and disinfection players to bring the company's competitive disinfection technology to market both inEurope and internationally. For further information, please contact: Geir Almås, CEO ofSoftOx Solutions AS Mail: ir@soft-ox.com Phone: Front Desk: (+47) 948-59-599 AboutSoftOx Solutions AS SoftOx Solutions AS (SoftOx, listed on Euronext Growth Oslo) is a Norwegian biopharmaceutical andMedTech company based inOslo , with the goal of reducing the spread of infection and emergence of antimicrobial resistance. For more information on SoftOx, visit www.soft-ox.com
Click here for more information
© Oslo Bors ASA, source